scholarly journals Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis

2013 ◽  
Vol 11 (2) ◽  
pp. 253-260 ◽  
Author(s):  
T. E. WARKENTIN ◽  
J. I. SHEPPARD ◽  
J. C. J. SUN ◽  
H. JUNG ◽  
J. W. EIKELBOOM
Keyword(s):  
Unfractionated Heparin ◽  
Bypass Surgery ◽  
Artery Bypass ◽  
Graft Occlusion ◽  
Venous Graft

Experimental Coronary Artery Occlusion: Relevance to Off-Pump Cardiac Surgery

2002 ◽  
Vol 10 (4) ◽  
pp. 293-297 ◽  
Author(s):  
Charles Hsi ◽  
Henri Cuenoud ◽  
Babs R Soller ◽  
Hun Kim ◽  
Janice Favreau ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Minimally Invasive ◽  
Coronary Artery Bypass ◽  
Bypass Surgery ◽  
Artery Bypass ◽  
Coronary Artery Occlusion ◽  
Artery Occlusion ◽  
Artery Dissection ◽  
Graft Occlusion ◽  
Off Pump

Mechanical coronary artery occlusion is required for minimally invasive direct coronary artery bypass and off-pump coronary artery bypass surgery. It is important that the method of occlusion be minimally traumatic. Chronic effects of these methods have never been studied. Temporary occlusion of coronaries utilizing suture snare, silastic loop snare, and bulldog clamp was carried out in 12 Yucatan pigs. Three animals each were sacrificed acutely and at 3, 6, and 12 months. The area of occlusion of each vessel was examined by light microscopy and the degree of damage recorded. In the animals sacrificed acutely, there was more damage using the suture snare than with the other 2 methods, but there was minimal damage at longer intervals. There was slight damage acutely and chronically with the bulldog technique. No damage was seen acutely with the silastic loop technique, but some late damage was found. The techniques of coronary artery dissection and occlusion used for minimally invasive and off-pump bypass surgery may contribute to early postoperative graft occlusion.

scholarly journals An unusual case of heart attack

2018 ◽  
Vol 0 (0) ◽  
Author(s):  
Joyce Kit-Yu Young ◽  
Daniel Kam Hung Ng
Keyword(s):  
Myocardial Infarction ◽  
Lupus Erythematosus ◽  
Heart Attack ◽  
Coronary Artery Bypass Surgery ◽  
Bypass Surgery ◽  
Unusual Case ◽  
Artery Bypass ◽  
Graft Occlusion ◽  
Systemic Lupus ◽  
The Impact

Abstract We reported a patient with antiphospholipid syndrome (APS) secondary to systemic lupus erythematosus (SLE) who suffered from myocardial infarction and graft occlusion after coronary artery bypass surgery. Our patient illustrates the impact of accelerated atherosclerosis in patients with SLE and APS and the importance of early institution of antithrombotic therapies. In this article, the treatment of APS is summarized. Although the main stay of treatment is anticoagulation, there is emerging evidence to support rituximab as an option for “refractory” cases of APS.

Pregnancy management for a patient with graft occlusion after right iliac artery bypass surgery

2014 ◽  
Vol 41 (6) ◽  
pp. 979-984 ◽  
Author(s):  
Ruriko Nakae ◽  
Shinya Matsuzaki ◽  
Tomomi Egawa-Takata ◽  
Kazuya Mimura ◽  
Takeshi Kanagawa ◽  
...  
Keyword(s):  
Iliac Artery ◽  
Bypass Surgery ◽  
Artery Bypass ◽  
Graft Occlusion

Activated protein C resistance and graft occlusion after coronary artery bypass surgery

1995 ◽  
Vol 79 (2) ◽  
pp. 223-226 ◽  
Author(s):  
Jan Eritsland ◽  
Gro Gjønnes ◽  
Per M. Sandset ◽  
Ingebjørg Seljeflot ◽  
Harald Arnesen
Keyword(s):  
Coronary Artery ◽  
Coronary Artery Bypass ◽  
Protein C ◽  
Coronary Artery Bypass Surgery ◽  
Bypass Surgery ◽  
Artery Bypass ◽  
Activated Protein C ◽  
Graft Occlusion ◽  
Activated Protein C Resistance

scholarly journals An unusual case of heart attack

2018 ◽  
Vol 18 (1) ◽  
pp. 7-13
Author(s):  
Joyce Kit-Yu Young ◽  
Daniel Kam Hung Ng
Keyword(s):  
Myocardial Infarction ◽  
Lupus Erythematosus ◽  
Heart Attack ◽  
Coronary Artery Bypass Surgery ◽  
Bypass Surgery ◽  
Unusual Case ◽  
Artery Bypass ◽  
Graft Occlusion ◽  
Systemic Lupus ◽  
The Impact

Abstract We reported a patient with antiphospholipid syndrome (APS) secondary to systemic lupus erythematosus (SLE) who suffered from myocardial infarction and graft occlusion after coronary artery bypass surgery. Our patient illustrates the impact of accelerated atherosclerosis in patients with SLE and APS and the importance of early institution of antithrombotic therapies. In this article, the treatment of APS is summarized. Although the main stay of treatment is anticoagulation, there is emerging evidence to support rituximab as an option for “refractory” cases of APS.

Sign in / Sign up

Export Citation Format

Share Document